Cargando…
OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets
Autores principales: | Wong, David C. S., Harvey, Joshua P., Jurkute, Neringa, Thomasy, Sara M., Moosajee, Mariya, Yu-Wai-Man, Patrick, Gilhooley, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Neuro-Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645107/ https://www.ncbi.nlm.nih.gov/pubmed/37974363 http://dx.doi.org/10.1097/WNO.0000000000001830 |
Ejemplares similares
-
Mitochondria and the eye—manifestations of mitochondrial diseases and their management
por: Chen, Benson S., et al.
Publicado: (2023) -
Reply: Spastic paraplegia in ‘dominant optic atrophy plus’ phenotype due to OPA1 mutation
por: Yu-Wai-Man, Patrick, et al.
Publicado: (2011) -
Loss of functional OPA1 unbalances redox state: implications in dominant optic atrophy pathogenesis
por: Millet, Aurélie M. C., et al.
Publicado: (2016) -
OPA1 mutations impair mitochondrial function in both pure and complicated dominant optic atrophy
por: Yu-Wai-Man, Patrick, et al.
Publicado: (2011) -
Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy
por: Kane, Mariame Selma, et al.
Publicado: (2017)